Axogen, Inc. — Director's Dealing 2015

Jan 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-01-02

Reporting Person: Harper John Frederick (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-02	Stock Option (right to purchase)	$4.81	A	15000	Acquired	2021-01-01	Common Stock (15000)	Direct
2015-01-02	Stock Option (right to purchase)	$3.60	A	15000	Acquired	2022-01-01	Common Stock (15000)	Direct

Footnotes

F1: Annual option grant as compensation for services on the board of directors. Options vest as to 25% of total share amount at the end of each fiscal quarter, becoming fully vested after one year.